Raia Drogasil S.A.
RADLY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $33 | $53 | $41 | $43 |
| - Cash | $1 | $0 | $0 | $0 |
| + Debt | $8 | $7 | $6 | $5 |
| Enterprise Value | $40 | $59 | $46 | $47 |
| Revenue | $39 | $34 | $29 | $24 |
| % Growth | 14.4% | 16.9% | 20.5% | – |
| Gross Profit | $12 | $10 | $9 | $7 |
| % Margin | 29.7% | 30% | 30.3% | 29.9% |
| EBITDA | $3 | $3 | $2 | $3 |
| % Margin | 8.1% | 8.1% | 8.4% | 10.9% |
| Net Income | $1 | $1 | $1 | $1 |
| % Margin | 3.1% | 3.1% | 3.4% | 3.1% |
| EPS Diluted | 0.72 | 0.62 | 0.58 | 0.44 |
| % Growth | 16.1% | 6.9% | 31.8% | – |
| Operating Cash Flow | $2 | $1 | $2 | $2 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | $1 | -$0 | $0 | $1 |